USPTO serial 79436392
UNIVERSAL BIOMOLECULAR MEDIUM
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- MURRAY, GEORGE WILLIAM
- Law office
- TMO LAW OFFICE 121
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with UNIVERSAL BIOMOLECULAR MEDIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nels T. Lippert
Nels T. Lippert Tarter Krinsky & Drogin LLP1350 Broadway, 11th Fl.New York, NY 10018United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations and chemical substances other than for medical or veterinary purposes, namely, for use in laboratory, analytical, diagnostic, clinical or medical applications, in particular for the preparation of media for the preservation and transport of DNA, RNA and proteins for the analysis of viruses, bacteria and other microorganisms; chemicals, chemical substances and molecules, and combinations thereof, other than for medical or veterinary purposes, namely, intended to facilitate chemical, molecular and biochemical analysis of biological and chemical samples and substances collected in a preservation and transport medium, all the aforesaid goods only for use with nasopharyngeal samples and urine and only for the analysis of respiratory viruses and Gram-positive bacteria, Gram-negative bacteria and fungi, to the exclusion of all other samples, microorganisms and uses | ACTIVE | — |
| 009 | Disposable devices, namely storage tubes and swabs for the collection, preservation and transport of biological and chemical samples and substances, not for medical use; scientific research specimen tubes containing preservation and transport media for viruses, bacteria and other microorganisms and their components, not for medical use; scientific research specimen tubes containing lysing and inactivating media for viruses, bacteria and other microorganisms, intended to preserve their components and macromolecules, not for medical use; scientific research specimen tubes containing media intended to preserve components and macromolecules of viruses, bacteria and other microorganisms, not for medical use; flocked swabs for the collection, preservation and transport of viruses, bacteria and other microorganisms and their components, not for medical use; swabs for the collection, preservation and transport of viruses, bacteria and other microorganisms and their components, not for medical use; containers and kits comprised primarily of sample vials and tubes for the preservation and transport of biological, chemical and diagnostic samples, not for medical use; containers and kits comprised primarily of sample vials and tubes for the lysis and inactivation of viruses, bacteria, other microorganisms and cells, not for medical use; containers and kits comprised primarily of sample vials and tubes for preserving components and macromolecules of viruses, bacteria and other microorganisms, not for medical use; kits comprising flocked swabs and scientific research specimen tubes containing preservation and transport media for viruses, bacteria and other microorganisms and their components, not for medical use; kits comprising swabs and scientific research specimen tubes containing preservation and transport media for viruses, bacteria and other microorganisms and their components, not for medical use; kits comprising flocked swabs and scientific research specimen tubes containing lysing and inactivating media for viruses, bacteria and other microorganisms, intended to preserve their components and macromolecules, not for medical use; kits comprising swabs and scientific research specimen tubes containing lysing and inactivating media for viruses, bacteria and other microorganisms, intended to preserve their components and macromolecules, not for medical use; kits comprising flocked swabs and scientific research specimen tubes containing media for preserving components and macromolecules of viruses, bacteria and other microorganisms, not for medical use; kits comprising swabs and scientific research specimen tubes containing media for preserving components and macromolecules of viruses, bacteria and other microorganisms, not for medical use, all the aforesaid goods only for use with nasopharyngeal samples and urine and only for the analysis of respiratory viruses and Gram-positive bacteria, Gram-negative bacteria and fungi, to the exclusion of all other samples, microorganisms and uses | ACTIVE | — |
| 010 | Disposable devices, namely, medical specimen tubes and swabs for the collection, preservation and transport of biological and chemical samples and substances, for medical use; medical specimen collection tubes containing preservation and transport media for viruses, bacteria and other microorganisms and their components, for medical use; medical specimen collection tubes containing lysing and inactivating media for viruses, bacteria and other microorganisms, intended to preserve their components and macromolecules, for medical use; medical specimen collection tubes containing media for preserving components and macromolecules of viruses, bacteria and other microorganisms, for medical use; containers and kits comprised primarily of medical sample vials and tubes for the transport and preservation of biological, chemical and diagnostic samples, for medical use; containers and kits comprised primarily of medical sample vials and tubes for the lysis and inactivation of viruses, bacteria, other microorganisms and cells, for medical use; containers and kits comprised primarily of medical sample vials and tubes for preserving components and macromolecules of viruses, bacteria and other microorganisms, for medical use; kits comprising medical sample vials and tubes containing preservation and transport media for viruses, bacteria and other microorganisms and their components, for medical use; kits comprising medical sample vials and tubes containing preservation and transport media for viruses, bacteria and other microorganisms and their components, for medical use; kits comprising medical sample vials and tubes containing lytic and inactivating media for viruses, bacteria and other microorganisms intended to preserve their components and macromolecules, for medical use; kits comprising medical sample vials and tubes containing media intended to preserve components and macromolecules of viruses, bacteria and other microorganisms, for medical use, all the aforesaid goods only for use with nasopharyngeal samples and urine and only for the analysis of respiratory viruses and Gram-positive bacteria, Gram-negative bacteria and fungi, to the exclusion of all other samples, microorganisms and uses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 12, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 12, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 7, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 19, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 19, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 13, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 12, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 6, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 6, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |